1. Bertonha, Fernanda Bernardi, Barros Filho, Mateus de Camargo, Kuasne, Hellen, Rainho, Claudia Aparecida, Rogatto, Silvia Regina. 2014. PHF21B as a candidate tumor suppressor gene in head and neck squamous cell carcinomas. In Molecular oncology, 9, 450-62. doi:10.1016/j.molonc.2014.09.009. https://pubmed.ncbi.nlm.nih.gov/25454821/
2. Wong, M-L, Arcos-Burgos, M, Liu, S, Bornstein, S R, Licinio, J. 2016. The PHF21B gene is associated with major depression and modulates the stress response. In Molecular psychiatry, 22, 1015-1025. doi:10.1038/mp.2016.174. https://pubmed.ncbi.nlm.nih.gov/27777418/
3. Basu, Amitava, Mestres, Iván, Sahu, Sanjeeb Kumar, Calegari, Federico, Tiwari, Vijay K. 2020. Phf21b imprints the spatiotemporal epigenetic switch essential for neural stem cell differentiation. In Genes & development, 34, 1190-1209. doi:10.1101/gad.333906.119. https://pubmed.ncbi.nlm.nih.gov/32820037/
4. Sheng, Siqi, Liu, Guannan, Lv, Pengcheng, Dong, Zengxiang, Shi, Yuanqi. 2025. Therapeutic inhibition of PHF21B attenuates pathological cardiac hypertrophy by inhibiting the BMP4/GSK3β/β-catenin axis. In European journal of pharmacology, 991, 177346. doi:10.1016/j.ejphar.2025.177346. https://pubmed.ncbi.nlm.nih.gov/39900327/